Edition:
United States

Vita 34 AG (V3VGn.DE)

V3VGn.DE on Xetra

5.71EUR
24 Feb 2017
Change (% chg)

€-0.07 (-1.21%)
Prev Close
€5.78
Open
€5.78
Day's High
€5.78
Day's Low
€5.71
Volume
4,428
Avg. Vol
6,697
52-wk High
€6.25
52-wk Low
€3.66

V3VGn.DE

Chart for V3VGn.DE

About

Vita 34 AG, is a Germany-based company that operates as an umbilical cord blood bank. It operates through the Stem Cell Storage and the Biotechnology segment. The Stem Cell Storage segment collects, processes, and stores stem cells from umbilical cord blood and umbilical cord tissue, as well as develops cell therapy procedures.... (more)

Overall

Beta: 0.08
Market Cap(Mil.): €17.28
Shares Outstanding(Mil.): 3.03
Dividend: 0.16
Yield (%): 2.80

Financials

  V3VGn.DE Industry Sector
P/E (TTM): 10.40 31.89 29.63
EPS (TTM): 0.55 -- --
ROI: 4.14 5.57 12.96
ROE: 6.67 8.86 14.11

BRIEF-Vita 34 FY sales revenues up at 16.2 million euros

* FY sales revenues increased in 2016 to a total of 16.2 million euros ($17.48 million)from 14.2 million euros achieved in commercial year 2015

Feb 01 2017

BRIEF-Vita 34 9-mth revenues up 16.9 pct to 12.0 million euros

* Was able to increase revenues in first nine months of 2016 by 16.9 percent to 12.0 million euros ($12.72 million) (first 9 months 2015: 10.3 million euros)

Nov 21 2016

BRIEF-Vita 34 expands its business in China

* Cooperation agreement was signed by CEO André Gerth, and CEO of Avic Biology, Wang Hualin Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Oct 20 2016

More From Around the Web

Earnings vs. Estimates